Sign in

CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330595156
Phone
512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. SC 13D/A Stake Beneficial Ownership Report
  2. 4 Open-market buy 10% owner bought 28,500 shares
  3. 4 Derivatives Options or other derivatives
  4. 8-K Event Regulation FD disclosure
  5. 8-K Event Executive or director change
  6. 4 Open-market buy Chief Executive Officer bought 9,493 shares at $2.42 ($22,973)
  7. 10-Q Report Quarterly Report
  8. 8-K Event Results of operations
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 8-K Event Shareholder vote results
  12. DEFA14A Proxy Proxy Materials
  13. 4 Derivatives Options or other derivatives
  14. 8-K Event Other events
  15. 424B5 Offering Prospectus
  16. 8-K Event Executive or director change
  17. EFFECT Other Notice of Effectiveness
  18. CORRESP Other Correspondence Between Filers and SEC Staff
  19. UPLOAD Other SEC-generated Letter
  20. S-3 Offering Registration Statement

Page 11 of 78 · 1,549 filings